newsfilter
← Latest News
Business Wire·

Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay

Hologic, Inc. (NASDAQ:HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company's Aptima® SARS-CoV-2 assay, which was first granted Emergency Use